Clinical Trial Update: A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

View source ↗

Summary

The update reports long-term safety data from a completed trial evaluating infliximab (Remicade) in patients with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Ulcerative Colitis | Status: COMPLETED